SCHEMBL204283

SCHEMBL204283

COC(=O)c1cccc(NC(=O)c2ccc(C3CCCN3C(=O)OCc3ccccc3)cc2F)c1O

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TMEM97 Q5BJF2 6/20 0.45
SIGMAR1 Q99720 6/20 0.45
ALDH1A1 P00352 1/20 0.45
TSHR P16473 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
GFER P55789 1/20 0.44
NPSR1 Q6W5P4 1/20 0.43
TP53 P04637 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
KDM1A O60341 1/20 0.40
RCOR1 Q9UKL0 1/20 0.40
HDAC1 Q13547 1/20 0.40
PREP P48147 1/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
ACE2 Q9BYF1 1/20 0.39
AADAT Q8N5Z0 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL205259 0.88 RIPK1 (0.41) ALDH1A1TSHRL3MBTL1NPSR1MEN1
SCHEMBL206142 0.88 TMEM97 (0.52) TMEM97SIGMAR1ALDH1A1TSHRL3MBTL1
SCHEMBL8248090 0.85 TMEM97 (0.55) TMEM97SIGMAR1ALDH1A1TSHRL3MBTL1
SCHEMBL206206 0.81 TMEM97 (0.56) TMEM97SIGMAR1ALDH1A1TSHRL3MBTL1
SCHEMBL206380 0.79 TSHR (0.66) ALDH1A1TSHRL3MBTL1GFERNPSR1
SCHEMBL205427 0.79 TMEM97 (0.53) TMEM97SIGMAR1ALDH1A1NPSR1KDM1A
SCHEMBL30930678 0.79 TMEM97 (0.58) TMEM97SIGMAR1ALDH1A1TSHRL3MBTL1
SCHEMBL4968298 0.78 SIGMAR1 (0.60) TMEM97SIGMAR1PREPAADAT
SCHEMBL29213817 0.78 SIGMAR1 (0.43) TMEM97SIGMAR1ALDH1A1NPSR1KDM1A
SCHEMBL29213869 0.78 SIGMAR1 (0.43) TMEM97SIGMAR1ALDH1A1NPSR1KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088760-B2 Benzoxazole carboxamide inhibitors of poly(ADP-ribose)polymerase (PARP) BIOMARIN PHARMACEUTICAL INC. (US) 2012-01-03 US disclosed
EP-2247600-A2 BENZOXAZOLE CARBOXAMIDE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) Lead Therapeutics, Inc. (US) 2010-11-10 EP disclosed
WO-2009099736-A2 BENZOXAZOLE CARBOXAMIDE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) LEAD THERAPEUTICS, INC. (US) 2009-08-13 WO disclosed
US-20090197863-A1 BENZOXAZOLE CARBOXAMIDE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) LEAD THERAPEUTICS, INC. (US) 2009-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090197863-A1 BENZOXAZOLE CARBOXAMIDE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) PARP1, PARP2, PARP11 TMEM97 4001/4885SIGMAR1 4024/4885ALDH1A1 398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.